AHealthyMe
-
Login Registration Sample personal Change Profile Log Out
Search AHealthyMe!  
Personalize AHealthyMe! -Sign up for our Newsletter!

Women's HealthMen's HealthHelath After 60Children's HealthPregnancyFitness & NutritionAlternative HealthLifestyle & WellnessWork & HealthIlls & ConditionsDental HealthSelf-Care CentersMedical LibraryCool ToolsMultimediaEn Español-

Blue Cross Blue Shield of Massachusetts

You are here: Home > Health A to Z > Hallervorden-Spatz disease



Hallervorden-Spatz disease

Definition
Expectations (prognosis)
Causes, incidence, and risk factors
Complications
Symptoms
Calling your health care provider
Signs and tests
Prevention
Treatment


 Definition  

Hallervorden-Spatz disease is a movement disorder that is passed down through families (inherited).

 Causes, incidence, and risk factors  

Hallervorden-Spatz is a disease that slowly gets worse (is degenerative). It usually begins in childhood. The condition involves muscle rigidity, weakness, and movement problems.

Most cases of Hallervorden-Spatz are due to a defect in a gene that makes a protein called pantothenate kinase 2. Patients with this genetic defect have a build up of iron in parts of the brain, especially the basal ganglia.

 Symptoms  

Symptoms typically begin in childhood and slowly get worse, often resulting in death by early adulthood. These include:

  • Dystonia
  • Stiff or rigid arms and legs
  • Tremor
  • Writhing movements
  • Dementia
  • Spasticity
  • Weakness
  • Seizures
  • Vision changes

 Signs and tests  

A neurological examination would show evidence of muscle rigidity, weakness, and abnormal postures, movements, and tremors. If other family members are also affected, this may help determine the diagnosis.

Genetic tests can confirm if the patient has the defect gene that causes the disease. However, this test is not yet widely available. Other movement disorders and diseases must be ruled out. An MRI usually shows iron deposits in the basal ganglia.

 Treatment  

The goal of treatment is to control the symptoms. Although there is no specific treatment for Hallervorden-Spatz disease, many believe taking certain vitamins may be beneficial, including pantothenate, Coenzyme Q, and other anti-oxidants.

 Expectations (prognosis)  

Hallervorden-Spatz is a progressive, degenerative nerve illness. It leads to early immobility and often death by early adulthood.

 Complications  

Complications may result from the medication used to treat symptoms. Immobility from the disease can also lead to skin breakdown, respiratory infections, and blood clots, among others.

 Calling your health care provider  

Call your health care provider if your child has symptoms of Hallervorden-Spatz disease.

 Prevention  

Genetic counseling is appropriate in families affected by this illness, as there is no known way to prevent it.

Review date: 8/26/2006

Reviewed By: Gail A. Kang, M.D., San Francisco VA Parkinson's Disease Research, Education, & Clinical Center, San Francisco, CA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.